USA - NASDAQ:NXL - US65345B2016 - Common Stock
Taking everything into account, NXL scores 3 out of 10 in our fundamental rating. NXL was compared to 191 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for NXL as it has an excellent financial health rating, but there are worries on the profitability. NXL is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -134.84% | ||
ROE | -148.42% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 67.68% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -8.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 10.44 | ||
Quick Ratio | 10.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.9349
+0.15 (+18.42%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 93.17 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.73 | ||
P/tB | 2.87 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -134.84% | ||
ROE | -148.42% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 67.68% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 83.24% | ||
Cap/Sales | 8.81% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 10.44 | ||
Quick Ratio | 10.15 | ||
Altman-Z | -8.55 |